PDCD1LG2 and neoplasm: Binding of the ligands PD-L1 or PD-L2, shown to be expressed by certain tumor cells, to the corresponding receptor induces T-cell anergy, unresponsiveness, and apoptosis of T-cells [6] and therefore leads to downregulation of the anti-tumor immune response.